Author

Afsaneh Asgharian

Observed names: A ASGHARIAN, A. Asgharian

Institution: University of North Carolina at Charlotte

Observed institutions: University of North Carolina at Charlotte, Pennsylvania State University, University of Arizona, Emory University, Long Island Jewish Medical Center, GlaxoSmithKline (United States), Maricopa Medical Center, University of North Carolina System, The Ohio State University, Penn State Milton S. Hershey Medical Center

OpenAlex ID: A5076190079

Seasonal Affective Disorder and Its Prevention by Anticipatory Treatment with Bupropion XL

2005 · Jack G. Modell, Norman E. Rosenthal, et al. · Biological Psychiatry · 124

Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis‐Ekbom Disease): Results from a prospective, multicenter study over 66 weeks

2012 · Diego García‐Borreguero, Birgit Högl, et al. · Movement Disorders · 77

Intravenous Ondansetron for Postsurgical Opioid-Induced Nausea and Vomiting

1997 · George W. Rung, Louis Claybon, et al. · Anesthesia & Analgesia · 42

Ropinirole in Patients With Restless Legs Syndrome and Baseline IRLS Total Scores ≥24: Efficacy and Tolerability in a 26-Week, Double-Blind, Parallel-Group, Placebo-Controlled Study Followed by a 40-Week Open-Label Extension

2013 · Luigi Giorgi, Afsaneh Asgharian, et al. · Clinical Therapeutics · 23

Patient- and Physician-Rated Measures Demonstrate the Effectiveness of Ropinirole in the Treatment of Restless Legs Syndrome

2008 · Clete A. Kushida, James Geyer, et al. · Clinical Neuropharmacology · 19

Long-term, Open-label Study of Once-daily Ropinirole Prolonged Release in Early Parkinson's Disease

2011 · Robert A. Hauser, Heinz Reichmann, et al. · International Journal of Neuroscience · 15

Long-term, open-label, safety study of once-daily ropinirole extended/prolonged release in early and advanced Parkinson's disease

2014 · Clare W. Makumi, Afsaneh Asgharian, et al. · International Journal of Neuroscience · 13

IBS prevalence: results from a community based patient registry based on the Rome II criteria

2000 · M.A. Markowitz, P. Jhingran, et al. · The American Journal of Gastroenterology · 8

Impact of differences in severity of irritable bowel syndrome (IBS) on patients' well being and resource use

2001 · J RICCI, P JHINGRAN, et al. · Gastroenterology · 6

Association Between the Affordable Care Act and Emergency Department Visits for Psychiatric Disease

2023 · Afsaneh Asgharian, Jane B. Neese, et al. · Western Journal of Emergency Medicine

Pmh12 Cost-effectiveness of Paliperidone Palmitate 3-month Versus 1-month for the Treatment of Schizophrenia in the United States

2019 · A. Asgharian, A.S. Khushalani, et al. · Value in Health

Irritable bowel syndrome (IBS) subtypes: Differences in QoL impairment, productivity loss, and resource use

2001 · M MARKOWITZ, P JHINGRAN, et al. · Gastroenterology

Differences in productivity QOL, and resource use in newly diagnosed and established irritable bowel syndrome (IBS) patients

2001 · P JHINGRAN, J RICCI, et al. · Gastroenterology

Works count: 13

Citation count: 327

H-index: 8

I10-index: 7